ID   MCRIi019-A
SY   1502; 1502.3; MCRIAi001-A
DR   hPSCreg; MCRIi019-A
DR   Wikidata; Q102114510
RX   PubMed=33002832;
RX   PubMed=33316599;
RX   PubMed=34543885;
CC   From: Murdoch Children's Research Institute; Melbourne; Australia.
CC   Population: African American.
CC   Derived from sampling site: Skin. Cell type=Fibroblast.
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_2766 ! WS1
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 16-12-21; Version: 5
RX   PubMed=33002832; DOI=10.1016/j.scr.2020.101962;
RA   Kung L.H.W., Sampurno L., Yammine K.M., Graham A., McDonald P.,
RA   Bateman J.F., Shoulders M.D., Lamande S.R.;
RT   "CRISPR/Cas9 editing to generate a heterozygous COL2A1 p.G1170S human
RT   chondrodysplasia iPSC line, MCRIi019-A-2, in a control iPSC line,
RT   MCRIi019-A.";
RL   Stem Cell Res. 48:101962-101962(2020).
RX   PubMed=33316599; DOI=10.1016/j.scr.2020.102118;
RA   Kung L.H.W., Sampurno L., Little C.B., Lamande S.R., Bateman J.F.;
RT   "Generation of a miR-26b stem-loop knockout human iPSC line,
RT   MCRIi019-A-1, using CRISPR/Cas9 editing.";
RL   Stem Cell Res. 50:102118-102118(2021).
RX   PubMed=34543885; DOI=10.1016/j.scr.2021.102515;
RA   Lilianty J., Bateman J.F., Lamande S.R.;
RT   "Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis
RT   mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.";
RL   Stem Cell Res. 56:102515-102515(2021).